Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NOVATO, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development […]
Evaxion Biotech Announces Closing of Private Placement
MSD Global Health Innovation Fund (MSD GHI), a corporate venture capital arm of Merck & Co., Inc., Rahway, NJ, USA, […]
Great Southern Bancorp, Inc. Announces Appointment of Amelia “Amy” Counts to Boards of Directors
SPRINGFIELD, Mo., Dec. 21, 2023 (GLOBE NEWSWIRE) — Great Southern Bancorp, Inc., (NASDAQ:GSBC), the holding company for Great Southern Bank, […]
CooperCompanies to Present at the J.P. Morgan Healthcare Conference
SAN RAMON, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) — CooperCompanies (Nasdaq: COO), a leading global medical device company, will participate […]
Presidio Regains Compliance with Nasdaq Minimum Bid Price Requirement
SAN DIEGO, Dec. 21, 2023 (GLOBE NEWSWIRE) — Presidio Property Trust, Inc. (“Presidio” or the “Company”) (NASDAQ: SQFT; SQFTP; SQFTW), […]
Lexicon Pharmaceuticals To Participate In The 42nd Annual JPMorgan Healthcare Conference
THE WOODLANDS, Texas, Dec. 21, 2023 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its participation in the […]
Alphatime Acquisition Corp Announces Adjournment of Extraordinary General Meeting of Shareholders
New York, New York, Dec. 21, 2023 (GLOBE NEWSWIRE) — Alphatime Acquisition Corp (Nasdaq: ATMC, ATMCU, ATMCR, and ATMCW) (the […]
Topline Results from MYLOX-1 Trial Demonstrate Reduction in Fibrosis of the Bone Marrow in Patients with Myelofibrosis
BOSTON, Dec. 21, 2023 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology company focused on the development […]
Mission Produce(TM) Announces Fiscal 2023 Fourth Quarter Financial Results
OXNARD, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) — Mission Produce, Inc. (Nasdaq: AVO) (“Mission” or the “Company”), a world leader […]
Clarion Clinics Receives Ethics Board Endorsement for the First Dedicated Psychedelic-Assisted Therapy Clinic in Australia
Highlights: Incannex subsidiary, Clarion Clinics, has received Human Research Ethics Committee (HREC) endorsement for administration of psychedelic-assisted therapies for TRD […]
